Invizyne Technologies, Inc

Paradigm Immunotherapeutics, Inc., based in Monrovia, CA, focuses on developing groundbreaking technologies aimed at combating BSL 3 and 4 infectious agents, including Ebola, as well as innovative treatments for immune-mediated diseases. The company operates at the forefront of medical advancements, although the co-development of intellectual property necessitates limited public disclosure. For accredited investors, Paradigm provides access to essential materials such as a pitch deck, term sheet, team information, an executive summary, FAQs, and budget details from 2016-2018 through a designated platform. This approach underscores the company’s commitment to fostering investment in its pioneering scientific endeavors. Generated from the website

Pace Diagnostics is an emerging biotechnology company based in Monrovia, CA, dedicated to the research, development, manufacturing, and marketing of cutting-edge diagnostics. With a focus on point-of-care rapid diagnostics, their innovative approach combines novel biomarkers with advanced diagnostic platforms to create breakthrough solutions for healthcare improvement. Supported by grants and contracts from the US Federal Government, Pace Diagnostics aims to revolutionize healthcare by providing instant diagnostics anywhere in the world. Their comprehensive portfolio includes the Tuberculosis Triage Screening Test, COVID-19 Antigen Rapid Detection Test, and Lung Cancer Early Detection Test, offering innovative solutions for early disease detection and screening.Generated from the website

Primordium Labs Inc., located in Arcadia, CA, specializes in whole-plasmid sequencing that simplifies the process for its customers. With no need for primers, users can conveniently drop off or mail their samples and receive results overnight for just $15 per sample. Trusted by top laboratories and institutions, Primordium Labs has earned a reputation for efficiency and reliability. Their straightforward approach eliminates hidden fees and provides a seamless experience, making plasmid sequencing easy and accessible for all users. Generated from the website